NOVEL PHOSPHATIDYLINOSITOL-3-KINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION
|Posted date||Jul 18, 2013|
|International application number||2012JP074542|
|International publication number||WO 2013/047509|
|Date of international filing||Sep 25, 2012|
|Date of international publication||Apr 4, 2013|
|Title||NOVEL PHOSPHATIDYLINOSITOL-3-KINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION|
The purpose of the present invention is to provide a novel PI3K inhibitor. The purpose of the present invention is also to provide a substance that combines a PI3K inhibitory effect and an HDAC inhibitory effect. Finally, the present invention further provides a novel anti-cancer pharmaceutical composition containing the substance, in particular an anti-cancer pharmaceutical composition that is effective even against intractable cancer. One embodiment of the present invention is a phosphatidylinositol-3-kinase (PI3K) inhibitor comprising a depsipeptide-class compound represented by formula (1), or a physiologically acceptable salt thereof.
|IPC(International Patent Classification)||
Contact Information for " NOVEL PHOSPHATIDYLINOSITOL-3-KINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION "
- Tohoku University Intellectual Property Division
- URL: http://www.rpip.tohoku.ac.jp/en/
- Address: 6-6-10 Aramaki Aza Aoba, Aoba-ku Sendai, Miyagi, JAPAN , 980-8579
- Fax: 81-22-795-5286